alpha-Synuclein: Multiple System Atrophy Prions

Autor: Woerman, AL, Watts, JC, Aoyagi, A, Giles, K, Middleton, LT, Prusiner, SB

Publikováno v: Woerman, AL; Watts, JC; Aoyagi, A; Giles, K; Middleton, LT; & Prusiner, SB. (2018). alpha-Synuclein: Multiple System Atrophy Prions. COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 8(7). doi: 10.1101/cshperspect.a024588. UCSF: Retrieved from: http://www.escholarship.org/uc/item/164159h3

Multiple system atrophy (MSA) is a rapidly progressive neurodegenerative disease arising from the misfolding and accumulation of the protein α-synuclein in oligodendrocytes, where it forms glial cytoplasmic inclusions (GCIs). Several years of studyi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::c169bb5c46d28832c9893c4fa55407fe
http://www.escholarship.org/uc/item/164159h3

Prevention of lower limb pain in soldiers using shock-absorbing orthotic inserts

Autor: Sherman, RA, Karstetter, KW, May, H, Woerman, AL

Publikováno v: Journal of the American Podiatric Medical Association (JAPMA); March 1996, Vol. 86 Issue: 3 p117-122, 6p

Research Priorities on the Role of α-Synuclein in Parkinson's Disease Pathogenesis.

Autor: Burré J; Appel Institute for Alzheimer's Disease Research and Brain and Mind Research Institute, Weill Cornell Medicine, New York, New York, USA., Edwards RH; Department of Physiology and Neurology, University of California, San Francisco School of Medicine, San Francisco, California, USA., Halliday G; Brain and Mind Centre, School of Medical Sciences, The University of Sydney, Camperdown, New South Wales, Australia., Lang AE; Edmond J. Safra Program in Parkinson's Disease, Krembil Research Institute, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada.; Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada., Lashuel HA; Laboratory of Chemical Biology of Neurodegeneration, Brain Mind Institute, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland., Melki R; Institut Francois Jacob (MIRCen), CEA and Laboratory of Neurodegenerative Diseases, CNRS, Fontenay-Aux-Roses, France., Murayama S; Department of Neuropathology, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Tokyo, Japan.; The Brain Bank for Neurodevelopmental, Neurological and Psychiatric Disorders, United Graduate School of Child Development, Osaka University, Osaka, Japan., Outeiro TF; Department of Experimental Neurodegeneration, University Medical Center, Göttingen, Germany.; Faculty of Medical Sciences, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom., Papa SM; Department of Neurology, School of Medicine, and Emory National Primate Research Center, Emory University, Atlanta, Georgia, USA., Stefanis L; First Department of Neurology, Eginitio Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.; Biomedical Research Foundation of the Academy of Athens, Athens, Greece., Woerman AL; Department of Biology, Institute for Applied Life Sciences, University of Massachusetts Amherst, Amherst, Massachusetts, USA.; Department of Microbiology, Immunology, and Pathology, Prion Research Center, Colorado State University, Fort Collins, Colorado, USA., Surmeier DJ; Department of Neuroscience, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.; Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, Maryland, USA., Kalia LV; Edmond J. Safra Program in Parkinson's Disease, Krembil Research Institute, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada.; Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada., Takahashi R; Department of Neurology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Publikováno v: Movement disorders : official journal of the Movement Disorder Society [Mov Disord] 2024 Oct; Vol. 39 (10), pp. 1663-1678. Date of Electronic Publication: 2024 Jun 30.

Effect of host and strain factors on α-synuclein prion pathogenesis.

Autor: Woerman AL; Department of Microbiology, Immunology, and Pathology, Prion Research Center, Colorado State University, Fort Collins, CO, USA. Electronic address: amanda.woerman@colostate.edu., Bartz JC; Department of Microbiology, Immunology, and Pathology, Prion Research Center, Colorado State University, Fort Collins, CO, USA; Department of Medical Microbiology and Immunology, School of Medicine, Creighton University, Omaha, NE, USA. Electronic address: jbartz@creighton.edu.

Publikováno v: Trends in neurosciences [Trends Neurosci] 2024 Jul; Vol. 47 (7), pp. 538-550. Date of Electronic Publication: 2024 May 27.

Are Preformed Fibrils a Model of Parkinson's Disease?

Autor: Woerman AL; Department of Microbiology, Immunology, and Pathology, Prion Research Center, Colorado State University, Fort Collins, CO, USA., Luk KC; Department of Pathology and Laboratory Medicine, Center for Neurodegenerative Disease Research, University of Pennsylvania, Philadelphia, PA, USA.

Publikováno v: Journal of Parkinson's disease [J Parkinsons Dis] 2024; Vol. 14 (6), pp. 1095-1103.